Browse > Article
http://dx.doi.org/10.7314/APJCP.2012.13.5.1963

The Metabolic Syndrome and Risk Factors for Biliary Tract Cancer: A Case-control Study in China  

Wu, Qiao (Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College)
He, Xiao-Dong (Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College)
Yu, Lan (Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College)
Liu, Wei (Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College)
Tao, Lian-Yuan (Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.13, no.5, 2012 , pp. 1963-1969 More about this Journal
Abstract
Objectives: Recent data show that the metabolic syndrome may play a role in several cancers, but the etiology for biliary tract cancer is incompletely defined. The present aim was to evaluate risk factors for biliary tract cancer in China. Methods: A case-control study in which cases were biliary tract cancer patients referred to Peking Union Medical College Hospital (PUMCH). Controls were randomly selected from an existing database of healthy individuals at the Health Screening Center of PUMCH. Data on the metabolic syndrome, liver diseases, family history, and history of diabetes and hypertension were collected by retrospective review of the patients' records and health examination reports or by interview. Results: A total of 281 patients (102 intrahepatic cholangiocarcinoma (ICC), 86 extrahepatic cholangiocarcinoma (ECC) and 93 gallbladder carcinoma (GC)) and 835 age- and sex-matched controls were enrolled. $HBsAg^+/anti-HBc^+$ (P=0.002), history of diabetes (P=0.000), cholelithiasis (P=0.000), TC (P=0.003), and HDL (P=0.000) were significantly related to ICC. Cholelithiasis (P=0.000), Tri (P=0.001), LDL (P=0.000), diabetes (P=0.000), Apo A (P=0.000) and Apo B (P=0.012) were significantly associated with ECC. Diabetes (P=0.017), cholelithiasis (P=0.000) and Apo A (P=0.000) were strongly inversely correlated with GC. Conclusion: Cholelithiasis, HBV infection and metabolic symptoms may be potential risk factors for the development of biliary tract cancer.
Keywords
Cholangiocarcinoma; gallbladder carcinoma; risk factors; metabolic syndrome;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Gatto M, Bragazzi MC, Semeraro R, et al (2010). Cholangiocarcinoma: update and future perspectives. Dig Liver Dis, 42, 253-60.   DOI
2 Giovannucci E (2001). Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr, 131, S3109-20.   DOI
3 Hammarsten J, Hogstedt B (2004). Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer. Blood Press, 13, 47-55.   DOI
4 Hardardottir I, Grunfeld C, Feingold KR(1994). Effects of endotoxin and cytokines on lipid metabolism. Curr Opin Lipidol, 5, 207-15.   DOI
5 Hou PC (1956). The relationship between primary carcinoma of the liver and infestation with Clonorchis sinensis. J Pathol Bacteriol, 72, 239-46.   DOI
6 Hsing AW, Gao YT, Devesa SS, et al (1998). Rising incidence of biliary tract cancers in Shanghai, China. Int J Cancer, 75, 368-70.   DOI
7 Hsing AW, Sakoda LC, Rashid A, et al (2008). Body size and the risk of biliary tract cancer: a population-based study in China. Br J Cancer, 99, 811-5.   DOI
8 Jaiswal M, LaRusso NF, Burgart LJ, et al (2000). Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res, 60, 184-90.
9 Khan SA, Toledano MB, Taylor-Robinson SD (2008). Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford), 10, 77-82.   DOI
10 Koga A, Ichimiya H, Yamaguchi K, et al (1985). Hepatolithiasis associated with cholangiocarcinoma. Possible etiologic significance. Cancer, 55, 2826-9.   DOI   ScienceOn
11 Lee MY, Lin KD, Hsiao PJ, et al (2011). The association of diabetes mellitus with liver, colon, lung, and prostate cancer is independent of hypertension, hyperlipidemia, and gout in Taiwanese patients. Metabolism, 61, 242-9.
12 Lee TY, Lee SS, Jung SW, et al (2008). Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study. Am J Gastroenterol, 103, 1716-20.   DOI   ScienceOn
13 Lepage C, Cottet V, Chauvenet M, et al (2011). Trends in the incidence and management of biliary tract cancer: a French population-based study. J Hepatol, 54, 306-10.   DOI
14 Liu XF, Zou SQ, Qiu FZ (2003). Pathogenesis of cholangiocarcinoma in the porta hepatis and infection of hepatitis virus. Hepatobiliary Pancreat Dis Int, 2, 285-9.
15 Matsuda T, Marugame T (2007). International comparisons of cumulative risk of gallbladder cancer and other biliary tract cancer, from Cancer Incidence in Five Continents Vol. VIII. Jpn J Clin Oncol, 37, 74-5.   DOI
16 Michalaki V, Koutroulis G, Syrigos K, et al (2005). Evaluation of serum lipids and high-density lipoprotein subfractions (HDL2, HDL3) in postmenopausal patients with breast cancer. Mol Cell Biochem, 268, 19-24.   DOI
17 Moerman CJ, Bueno-de-Mesquita HB (1999). The epidemiology of gallbladder cancer: lifestyle related risk factors and limited surgical possibilities for prevention. Hepatogastroenterology, 46, 1533-9.
18 Nijhawan PK, Therneau TM, Dickson ER, et al (1999). Incidence of cancer in primary biliary cirrhosis: the Mayo experience. Hepatology, 29, 1396-8.   DOI
19 Ohshima H, Tatemichi M, Sawa T (2003). Chemical basis of inflammation-induced carcinogenesis. Arch Biochem Biophys, 417, 3-11.   DOI
20 Park J, Tadlock L, Gores GJ, et al (1999). Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line. Hepatology, 30, 1128-33.   DOI   ScienceOn
21 Patel T (2001). Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology, 33, 1353-7.   DOI   ScienceOn
22 Patel T (2006). Cholangiocarcinoma. Nat Clin Pract Gastroenterol Hepatol, 3, 33-42.   DOI   ScienceOn
23 Perumal V, Wang J, Thuluvath P, et al (2006). Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States. Hum Pathol, 37, 1211-6.   DOI
24 Randi G, Franceschi S, La Vecchia C (2006). Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer, 118, 1591-602.   DOI   ScienceOn
25 Rashid A, Ueki T, Gao YT, et al (2002). K-ras mutation, p53 overexpression, and microsatellite instability in biliary tract cancers: a population-based study in China. Clin Cancer Res, 8, 3156-63.
26 Reeves ME, DeMatteo RP (2000). Genes and viruses in hepatobiliary neoplasia. Semin Surg Oncol, 19, 84-93.   DOI   ScienceOn
27 Sandoh N, Shirai Y, Hatakeyama K (1997). Incidence of anomalous union of the pancreaticobiliary ductal system in biliary cancer. Hepatogastroenterology, 44, 1580-3.
28 Seccia M, Cavina E (1989). [Risk factors and etiopathogenesis of cancer of the gallbladder]. Ann Ital Chir, 60, 163-71; discussion 172.
29 Shaib Y, El-Serag HB (2004). The epidemiology of cholangiocarcinoma. Semin Liver Dis, 24, 115-25.   DOI   ScienceOn
30 Shaib YH, El-Serag HB, Davila JA, et al (2005). Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology, 128, 620-6.   DOI   ScienceOn
31 Shaib YH, El-Serag HB, Nooka AK, et al (2007). Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am J Gastroenterol, 102, 1016-21.   DOI
32 Shebl FM, Andreotti G, Meyer TE, et al (2011). Metabolic syndrome and insulin resistance in relation to biliary tract cancer and stone risks: a population-based study in Shanghai, China. Br J Cancer, 105, 1424-9.   DOI   ScienceOn
33 Shebl FM, Andreotti G, Rashid A, et al (2010). Diabetes in relation to biliary tract cancer and stones: a population-based study in Shanghai, China. Br J Cancer, 103, 115-9.   DOI
34 Shi JS, Zhou LS, Han Y, et al (2004). Expression of tumor necrosis factor and its receptor in gallstone and gallbladder carcinoma tissue. Hepatobiliary Pancreat Dis Int, 3, 448-52.
35 Suzuki H, Li Y, Dong X, et al (2008). Effect of insulin-like growth factor gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev, 17, 3467-73.   DOI
36 Tang ZY, Guo EQ, Yan HC, et al (2007). Risk factors for infectious morbidity in gallbladder cancer patients treated surgically. Hepatogastroenterology, 54, 22-7.
37 Tao LY, He XD, Qu Q, et al (2010). Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China. Liver Int, 30, 215-21.   DOI
38 Wells BJ, Mainous AG, 3rd, et al (2005). Iron, cholesterol, and the risk of cancer in an 18-year cohort. Asian Pac J Cancer Prev, 6, 505-9.
39 Tomimatsu M, Ishiguro N, Taniai M, et al (1993). Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan. Cancer, 72, 683-8.   DOI
40 Tyson GL, El-Serag HB(2011). Risk factors of cholangiocarcinoma. Hepatology, 54, 173-84
41 Welzel TM, Graubard BI, El-Serag HB, et al (2007) Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol, 5, 1221-8.   DOI
42 Welzel TM, McGlynn KA, Hsing AW, et al (2006). Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst, 98, 873-5.   DOI
43 Welzel TM, Mellemkjaer L, Gloria G, et al (2007). Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study. Int J Cancer, 120, 638-41.   DOI   ScienceOn
44 West J, Wood H, Logan RF, et al (2006). Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001. Br J Cancer, 94, 1751-8.   DOI
45 Wijaya I, Abdullah M (2011). Diagnosis and treatment update: cholangiocarcinoma. Acta Med Indones, 43, 212-5.
46 Yamamoto S, Kubo S, Hai S, et al (2004). Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma. Cancer Sci, 95, 592-5.   DOI
47 Alvaro D, Barbaro B, Franchitto A, et al (2006). Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma. Am J Pathol, 169, 877-88.   DOI
48 Zhou HB, Wang H, Zhou DX, et al (2010). Etiological and clinicopathologic characteristics of intrahepatic cholangiocarcinoma in young patients. World J Gastroenterol, 16, 881-5.
49 Zhou YM, Yin ZF, Yang JM, et al (2008). Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China. World J Gastroenterol, 14, 632-5.   DOI
50 Zou S, Zhang L (2000). Relative risk factors analysis of 3,922 cases of gallbladder cancer. Zhonghua Wai Ke Za Zhi, 38, 805-8.
51 Benitez S, Camacho M, Bancells C, et al (2006). Wide proinflammatory effect of electronegative low-density lipoprotein on human endothelial cells assayed by a protein array. Biochim Biophys Acta, 1761, 1014-21.   DOI
52 Ben-Menachem T(2007). Risk factors for cholangiocarcinoma. Europ J Gastroenterol Hepatol, 19, 615-7.   DOI
53 El-Serag HB, Hampel H, Javadi F (2006). The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol, 4, 369-80.   DOI   ScienceOn
54 Ben Q, Cai Q, Li Z, et al (2011). The relationship between new-onset diabetes mellitus and pancreatic cancer risk: a case-control study. Eur J Cancer, 47, 248-54.   DOI
55 Cai HH, Sun YM, Bai JF, et al (2008). Relationship between the GH-IGFs axis and the proliferation of bile duct cancer cell line QBC939 in vitro. Hepatobiliary Pancreat Dis Int, 7, 76-81.
56 Cardinale V, Semeraro R, Torrice A, et al (2010). Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors. World J Gastrointest Oncol, 2, 407-16.   DOI   ScienceOn
57 Federico A, Morgillo F, Tuccillo C, et al (2007). Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer, 121, 2381-6.   DOI   ScienceOn
58 Feig DI, Sowers LC, Loeb LA (1994). Reverse chemical mutagenesis: identification of the mutagenic lesions resulting from reactive oxygen species-mediated damage to DNA. Proc Natl Acad Sci USA, 91, 6609-13.   DOI   ScienceOn
59 Feingold KR, Soued M, Adi S, et al (1990). Tumor necrosis factor-increased hepatic very-low-density lipoprotein production and increased serum triglyceride levels in diabetic rats. Diabetes, 39, 1569-74.   DOI
60 Festi D, Dormi A, Capodicasa S, et al (2008). Incidence of gallstone disease in Italy: results from a multicenter, population-based Italian study (the MICOL project). World J Gastroenterol, 14, 5282-9.   DOI
61 Furberg AS, Veierod MB, Wilsgaard T, et al (2004). Serum highdensity lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst, 96, 1152-60.   DOI